Behavior and Biology: The Basic Sciences for AHA Action

Slides:

Advertisements

Similar presentations

Robert M. Guthrie, MD Professor of Emergency Medicine

Advertisements

YOUR CHOLESTEROL WHY DO YOU CARE? WHAT YOU CAN DO !

Cumulative Radiation Exposure and Cancer Risk Estimation in Children With Heart DiseaseCLINICAL PERSPECTIVE by Jason N. Johnson, Christoph P. Hornik, Jennifer.

by , Rita F. Redberg, Emelia J. Benjamin, Vera Bittner, Lynne T

Early Outcomes of Tricuspid Valve Replacement in Young Children by Heather L. Bartlett, Dianne L. Atkins, Trudy L. Burns, Kelly J. Engelkes, Sarah J. Powell,

Bariatric Surgery and Cardiovascular Risk Factors by Paul Poirier, Marc-André Cornier, Theodore Mazzone, Sasha Stiles, Susan Cummings, Samuel Klein, Peter.

Omega-3 Fatty Acid Blood Levels by H. Robert Superko, Scott M. Superko, Khurram Nasir, Arthur Agatston, and Brenda C. Garrett Circulation Volume 128(19):

Hypercholesterolemia Enhances Thromboembolism in Arterioles but Not Venules by Martijn A.W. Broeders, Geert Jan Tangelder, Dick W. Slaaf, Robert S. Reneman,

Can Adenosine 5′-Triphosphate Be Used to Select Treatment in Severe Vasovagal Syndrome? by Daniel Flammang, Timothy Church, Marc Waynberger, Annick Chassing,

Stepwise approach to assessing cardiac patient risk for noncardiac surgery. (Reproduced, with permission, from Fleisher LA et al. ACC/AHA 2007 Guidelines.

Stepwise approach to assessing cardiac patient risk for noncardiac surgery. (Reproduced, with permission, from Fleisher LA et al. ACC/AHA 2007 Guidelines.

Algorithm for guideline-directed medical therapy for patients with stable ischemic heart disease. The use of bile acid sequestrant is relatively contraindicated.

Copyright © 2005 American Medical Association. All rights reserved.

Algorithm for the management of aortic valve stenosis

Percentage of Community-Dwelling Adults Ages 18 and Older Who Had Their Blood Cholesterol Checked Within the Past Five Years, 1998 and 2003 Data: National.

Hypothetical distribution of test results for healthy and diseased individuals. The position of the "cutoff point" between "normal" and "abnormal" (or.

Major recommendation for statin therapy for ASCVD prevention

Sectional View of Heart

In diastolic dysfunction, the diastolic pressure-volume relationship is shifted upward and to the left (dashed line), which leads to an elevated left ventricular.

Predicted 5-year benefits of LDL cholesterol reductions with statin treatment at different levels of risk. (A) Major vascular events, and (B) vascular.

Recommended heart donor management algorithm

Driving Times and Distances to Hospitals With Percutaneous Coronary Intervention in the United States by Brahmajee K. Nallamothu, Eric R. Bates, Yongfei.

Copyright © 2017 American Academy of Pediatrics.

Kaplan-Meier survival for adult heart transplants performed between January 1982 and June 2006 by era. All comparisons are significant at p < (Reproduced.

Adapted with permission from Hsia, J et al

Adult basic life support health care provider algorithm

(From Stone NJ, Robinson JG, Lichtenstein AH, et al

Algorithm for guideline-directed medical therapy for patients with SIHD. Colors correspond to the class of recommendations in the ACCF/AHATable The.

Copyright © The McGraw-Hill Companies, Inc

Circ Cardiovasc Qual Outcomes

American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular.

Three-dimensional Mapping of the Initiation of Nonsustained Ventricular Tachycardia in the Human Heart by Mina K. Chung, Steven M. Pogwizd, Dave P. Miller,

by Yehuda G. Wolf, Christopher K. Zarins, Geoffrey D

Arterioscler Thromb Vasc Biol

by Salim Yusuf, and Sonia Anand

Insulin Resistance as an Independent Risk Factor for Carotid Wall Thickening by Masaaki Suzuki, Kazuya Shinozaki, Akio Kanazawa, Yasushi Hara, Yuichi Hattori,

Association of Lipids With Incident Heart Failure Among Adults With and Without Diabetes MellitusClinical Perspective by Imo A. Ebong, David C. Goff, Carlos.

Prehypertension, Diabetes, and Cardiovascular Disease Risk in a Population-Based Sample by Ying Zhang, Elisa T. Lee, Richard B. Devereux, Jeunliang Yeh,

by Kiran Musunuru, and Sekar Kathiresan

Circ Cardiovasc Qual Outcomes

So Far, PCSK9 Inhibitors Work for All Heterozygous FH Patients

Effect of Low Cholesterol on Steroid Hormones and Vitamin E Levels

Arterioscler Thromb Vasc Biol

by Thomas Monks, Martin Pitt, Ken Stein, and Martin James

Relative Distributions

Contribution of Stroke to the Cochrane Stroke Group Trials Register

New Frontiers in Cardiology

Virtual Reality in Stroke Rehabilitation

Infusion of CSL112 increases total cholesterol efflux capacity (CEC) regardless of baseline functional apolipoprotein A-I (apoA-I) activity. Infusion of.

Mathematical representation of Bayes theorem.

Chapter 2: Pharmacological cholesterol-lowering treatment in adults

Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN

Martin W. Schoen, MD, MPH, Joanne Salas, MPH, Jeffrey F

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update

Obsessive Compulsive Disorder: A Clinical Update

Metabolic Complications in Elderly Adults With CKD

James H. O'Keefe, M.D., Carl J. Lavie, M.D., Ben D. McCallister, M.D.

Meredith Kilgore, PhD, Paul Muntner, PhD, J

Ali A. Hasnie, MD, Ashok Kumbamu, PhD, Maya S

Baseline Characteristics, Values at 24-Month Follow-up, and Changes from Baseline* - Part I John J.P. Kastelein, et al. N Engl J Med 2007;356: online.

Copyright © The McGraw-Hill Companies, Inc

High-Density Lipoprotein Cholesterol Function Improves after Successful Treatment of Psoriasis: A Step Forward in the Right Direction Nehal N. Mehta,

Insomnia in the Elderly: Cause, Approach, and Treatment

(A) Low-density lipoprotein-cholesterol (LDL-C) values at baseline and after treatment with anagliptin in 20 participants at 12 and 24 weeks. (A) Low-density.

Titration activities from baseline up to 6 and 12 months follow-up in nurse-coordinated care (NCC) versus usual care patients. X-as: patients (percentage),

Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease Dean G. Karalis, MD Mayo Clinic Proceedings

III. Treating dyslipidemias

J. David Spence, BA, MBA, MD Canadian Journal of Cardiology

Jenna Barton, MSN, RN-C, PCCN

The cumulative incidence curve demonstrated that patients with a sub-optimal LDL-C response to statin therapy were associated with a higher risk of CVD.

Presentation transcript:

Behavior and Biology: The Basic Sciences for AHA Action by Martha N. Hill Circulation Volume 97(8):807-810 March 3, 1998 Copyright © American Heart Association, Inc. All rights reserved.

Distribution of low-density lipoprotein cholesterol (LDL-C) levels. Distribution of low-density lipoprotein cholesterol (LDL-C) levels. ATP-I indicates 1988 Adult Treatment Panel; ATP-II, 1993 Adult Treatment Panel. From Schroft et al.2 Copyright 1997 by the American Medical Association. Reproduced with permission. Martha N. Hill Circulation. 1998;97:807-810 Copyright © American Heart Association, Inc. All rights reserved.